Chlorogenic acid alleviates renal fibrosis by reducing lipid accumulation in diabetic kidney disease through suppressing the Notch1 and Stat3 signaling pathway

References

• Sun H, Saeedi P, Karuranga S, et al. IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183:1. doi: 10.1016/j.diabres.2021.109119.
   Web of Science ®Google Scholar
• Nogueira A, Pires MJ, Oliveira PA. Pathophysiological mechanisms of renal fibrosis: a review of animal models and therapeutic strategies. In Vivo. 2017;31(1):1–14. doi: 10.21873/invivo.11019.
   PubMed Web of Science ®Google Scholar
• Xiang E, Han B, Zhang Q, et al. Human umbilical cord-derived mesenchymal stem cells prevent the progression of early diabetic nephropathy through inhibiting inflammation and fibrosis. Stem Cell Res Ther. 2020;11(1):336. doi: 10.1186/s13287-020-01852-y.
   PubMed Web of Science ®Google Scholar
• Herman-Edelstein M, Scherzer P, Tobar A, et al. Altered renal lipid metabolism and renal lipid accumulation in human diabetic nephropathy. J Lipid Res. 2014;55:561–572. doi: 10.1194/jlr.P040501.
   Google Scholar
• Yuan Y, Sun H, Sun Z. Advanced glycation end products (AGEs) increase renal lipid accumulation: a pathogenic factor of diabetic nephropathy (DN). Lipids Health Dis. 2017;16:126. doi: 10.1186/s12944-017-0522-6.
   Google Scholar
• Guebre-Egziabher F, Alix PM, Koppe L, et al. Ectopic lipid accumulation: a potential cause for metabolic disturbances and a contributor to the alteration of kidney function. Biochimie. 2013;95(11):1971–1979. doi: 10.1016/j.biochi.2013.07.017.
   PubMed Web of Science ®Google Scholar
• Wang Z, Jiang T, Li J, et al. Regulation of renal lipid metabolism, lipid accumulation, and glomerulosclerosis in FVBdb/db mice with type 2 diabetes. Diabetes. 2005;54(8):2328–2335. doi: 10.2337/diabetes.54.8.2328.
   PubMed Web of Science ®Google Scholar
• Murea M, Freedman BI, Parks JS, et al. Lipotoxicity in diabetic nephropathy: the potential role of fatty acid oxidation. Clin J Am Soc Nephrol. 2010;5(12):2373–2379. doi: 10.2215/CJN.08160910.
   PubMed Web of Science ®Google Scholar
• Naso LG, Valcarcel M, Roura-Ferrer M, et al. Promising antioxidant and anticancer (human breast cancer) oxidovanadium(IV) complex of chlorogenic acid synthesis, characterization and spectroscopic examination on the transport mechanism with bovine serum albumin. J Inorg Biochem. 2014;135:86–99. doi: 10.1016/j.jinorgbio.2014.02.013.
   PubMed Web of Science ®Google Scholar
• Ferrare K, Bidel LPR, Awwad A, et al. Increase in insulin sensitivity by the association of chicoric acid and chlorogenic acid contained in a natural chicoric acid extract (NCRAE) of chicory (Cichorium intybus L.) for an antidiabetic effect. J Ethnopharmacol. 2018;215:241–248. doi: 10.1016/j.jep.2017.12.035.
   PubMed Web of Science ®Google Scholar
• Venditti A, Bianco A, Frezza C, et al. Essential oil composition, polar compounds, glandular trichomes and biological activity of Hyssopus officinalis subsp. aristatus (Godr.) Nyman from central Italy. Ind Crops Products. 2015;77:353–363. doi:10.1016/j.indcrop.2015.09.002.
   Web of Science ®Google Scholar
• Jin S, Chang C, Zhang L, et al. Chlorogenic acid improves late diabetes through adiponectin receptor signaling pathways in db/db Mice. PLoS One. 2015;10(4):e0120842. doi: 10.1371/journal.pone.0120842.
   PubMed Web of Science ®Google Scholar
• Huang K, Liang XC, Zhong YL, et al. 5‐Caffeoylquinic acid decreases diet‐induced obesity in rats by modulating PPARα and LXRα transcription. J Sci Food Agric. 2015;95(9):1903–1910. doi: 10.1002/jsfa.6896.
   PubMed Web of Science ®Google Scholar
• Xiang C, Li Y, Xiao Y, et al. Chlorogenic acid-enriched extract from Eucommia ulmoides leaves inhibits hepatic lipid accumulation through regulation of cholesterol metabolism in HepG2 cells. Pharm Biol. 2016;54(2):251–259. doi: 10.3109/13880209.2015.1029054.
   PubMed Web of Science ®Google Scholar
• Bajko E, Kalinowska M, Borowski P, et al. 5-O-Caffeoylquinic acid: a spectroscopic study and biological screening for antimicrobial activity. LWT Food Sci Technol. 2016;65:471–479. doi: 10.1016/j.lwt.2015.08.024.
   Web of Science ®Google Scholar
• Tsai KL, Hung CH, Chan SH, et al. Chlorogenic acid protects against oxLDL-induced oxidative damage and mitochondrial dysfunction by modulating SIRT1 in endothelial cells. Mol Nutr Food Res. 2018;62(11):e1700928. doi: 10.1002/mnfr.201700928.
   PubMed Web of Science ®Google Scholar
• Ali N, Rashid S, Nafees S, et al. Protective effect of chlorogenic acid against methotrexate induced oxidative stress, inflammation and apoptosis in rat liver: an experimental approach. Chem Biol Interact. 2017;272:80–91. doi: 10.1016/j.cbi.2017.05.002.
   PubMed Web of Science ®Google Scholar
• Bao L, Li J, Zha D, et al. Chlorogenic acid prevents diabetic nephropathy by inhibiting oxidative stress and inflammation through modulation of the Nrf2/HO-1 and NF-B pathways. Int Immunopharmacol. 2017;54:245–253. doi: 10.1016/j.intimp.2017.11.021.
   Web of Science ®Google Scholar
• Perdigoto CN, Bardin AJ. Sending the right signal: notch and stem cells. .Biochim Biophys Acta. 2013;1830:2307–2322. doi: 10.1016/j.bbagen.2012.08.009.
   Google Scholar
• Park JS, Kim SH, Kim K, et al. Inhibition of notch signalling ameliorates experimental inflammatory arthritis. Ann Rheum Dis J Clin Rheumatol Connect Tissue Res. 2015;74:267–274. doi: 10.1136/annrheumdis-2013-203467.
   Google Scholar
• Kopan R, Ilagan MXG. The canonical notch signaling pathway: unfolding the activation mechanism. Cell. 2009;137(2):216–233. doi: 10.1016/j.cell.2009.03.045.
   PubMed Web of Science ®Google Scholar
• Xu H, Wang L. The role of notch signaling pathway in non-alcoholic fatty liver disease. Front Mol Biosci. 2021;8:792667. doi: 10.3389/fmolb.2021.792667.
   PubMed Web of Science ®Google Scholar
• Song NJ, Yun UJ, Yang S, et al. Notch1 deficiency decreases hepatic lipid accumulation by induction of fatty acid oxidation. Sci Rep. 2016;6(1):19377. doi: 10.1038/srep19377.
   PubMedGoogle Scholar
• Bi P, Kuang S. Notch signaling as a novel regulator of metabolism. Trend Endocrinol Metab. 2015;26(5):248–255. doi: 10.1016/j.tem.2015.02.006.
   PubMed Web of Science ®Google Scholar
• Matsui F, Meldrum KK. The role of the Janus kinase family/signal transducer and activator of transcription signaling pathway in fibrotic renal disease. J Surg Res. 2012;178(1):339–345. doi: 10.1016/j.jss.2012.06.050.
   PubMed Web of Science ®Google Scholar
• Zheng C, Huang L, Luo W, et al. Inhibition of STAT3 in tubular epithelial cells prevents kidney fibrosis and nephropathy in STZ-induced diabetic mice. Cell Death Dis. 2019;10(11):848. doi: 10.1038/s41419-019-2085-0.
   PubMedGoogle Scholar
• Sun Q, Wang X, Xin X, et al. Qushi Huayu decoction attenuated hepatic lipid accumulation via JAK2/STAT3/CPT-1A-related fatty acid β-oxidation in mice with non-alcoholic steatohepatitis. Pharm Biol. 2022;60(1):2124–2133. doi: 10.1080/13880209.2022.2134898.
   PubMed Web of Science ®Google Scholar
• Kamakura S, Oishi K, Yoshimatsu T, et al. Hes binding to STAT3 mediates crosstalk between Notch and JAK-STAT signalling. Nat Cell Biol. 2004;6(6):547–554. doi: 10.1038/ncb1138.
   PubMed Web of Science ®Google Scholar
• Xiang J, Zhang H, Zhou X, et al. Atorvastatin restores PPARα inhibition of lipid metabolism disorders by downregulating miR-21 expression to improve mitochondrial function and alleviate diabetic nephropathy progression. Front Pharmacol. 2022;13:819787. doi: 10.3389/fphar.2022.819787.
   PubMed Web of Science ®Google Scholar
• Eugene H, Eugene S, Gyuri K, et al. Combining SGLT2 inhibition with a thiazolidinedione additively attenuate the very early phase of diabetic nephropathy progression in type 2 diabetes mellitus. Front Endocrinol. 2018;9:412.
   PubMed Web of Science ®Google Scholar
• Chen L, Cao G, Wang M, et al. The matrix metalloproteinase-13 inhibitor poricoic acid ZI ameliorates renal fibrosis by mitigating epithelial-mesenchymal transition. Mol Nutr Food Res. 2019;63:e1900132. doi: 10.1002/mnfr.201900132.
   Web of Science ®Google Scholar
• Yan Y, Zhou X, Guo K, et al. Use of chlorogenic acid against diabetes mellitus and its complications. J Immunol Res. 2020;2020:9680508–9680506. doi: 10.1155/2020/9680508.
   PubMed Web of Science ®Google Scholar
• Ye HY, Li ZY, Zheng Y, et al. The attenuation of chlorogenic acid on oxidative stress for renal injury in streptozotocin-induced diabetic nephropathy rats. Arch Pharm Res. 2016;39(7):989–997. doi: 10.1007/s12272-016-0771-3.
   PubMed Web of Science ®Google Scholar
• Kanwar YS, Sun L, Xie P, et al. A glimpse of various pathogenetic mechanisms of diabetic nephropathy. Annu Rev Pathol. 2011;6(1):395–423. doi: 10.1146/annurev.pathol.4.110807.092150.
   PubMed Web of Science ®Google Scholar
• Opazo-Ríos L, Mas S, Marín-Royo G, et al. Lipotoxicity and diabetic nephropathy: novel mechanistic insights and therapeutic opportunities. Int J Mol Sci. 2020;21(7):21. doi: 10.3390/ijms21072632.
   Web of Science ®Google Scholar
• H VS, K V, Patel D, et al. Biomechanism of chlorogenic acid complex mediated plasma free fatty acid metabolism in rat liver. BMC Complement Altern Med. 2016;16:274. doi: 10.1186/s12906-016-1258-y.
   PubMed Web of Science ®Google Scholar
• Karthikesan K, Pari L, Menon VP. Combined treatment of tetrahydrocurcumin and chlorogenic acid exerts potential antihyperglycemic effect on streptozotocin-nicotinamide-induced diabetic rats. Gen Physiol Biophys. 2010;29(1):23–30. doi: 10.4149/gpb_2010_01_23.
   PubMed Web of Science ®Google Scholar
• Ma TT, Meng XM. TGF-β/Smad and renal fibrosis. Adv Exp Med Biol. 2019;1165:347–364. doi: 10.1007/978-981-13-8871-2_16.
   PubMed Web of Science ®Google Scholar
• Wu W, Wang X, Yu X, et al. Smad3 signatures in renal inflammation and fibrosis. Int J Biol Sci. 2022;18(7):2795–2806. doi: 10.7150/ijbs.71595.
   PubMed Web of Science ®Google Scholar
• Ren LL, Li XJ, Duan TT, et al. Transforming growth factor-β signaling: from tissue fibrosis to therapeutic opportunities. Chem Biol Interact. 2023;369:110289. doi: 10.1016/j.cbi.2022.110289.
   PubMed Web of Science ®Google Scholar
• Wang L, Wang HL, Liu TT, et al. TGF-beta as a master regulator of diabetic nephropathy. Int J Mol Sci. 2021;22(15):22. doi: 10.3390/ijms22157881.
   Web of Science ®Google Scholar
• Sun L, Halaihel N, Zhang W, et al. Role of sterol regulatory element-binding protein 1 in regulation of renal lipid metabolism and glomerulosclerosis in diabetes mellitus. J Biol Chem. 2002;277(21):18919–18927. doi: 10.1074/jbc.M110650200.
   PubMed Web of Science ®Google Scholar
• Kang HM, Ahn SH, Choi P, et al. Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development. Nat Med. 2015;21(1):37–46. doi: 10.1038/nm.3762.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Jin D, Kang X, et al. Signaling pathways involved in diabetic renal fibrosis. Front Cell Dev Biol. 2021;9:696542. doi: 10.3389/fcell.2021.696542.
   PubMed Web of Science ®Google Scholar